These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6976847)

  • 1. Pharmacology of 8-aminoquinolines.
    Grewal RS
    Bull World Health Organ; 1981; 59(3):397-406. PubMed ID: 6976847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New tissue schizontocidal antimalarial drugs.
    Davidson DE; Ager AL; Brown JL; Chapple FE; Whitmire RE; Rossan RN
    Bull World Health Organ; 1981; 59(3):463-79. PubMed ID: 6976854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of some 4-substituted 8-amino-6-methoxyquinolines as potential antimalarials.
    Carroll FI; Berrang B; Linn CP; Twine CE
    J Med Chem; 1979 Jun; 22(6):694-9. PubMed ID: 110932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causal prophylactic efficacy of primaquine, tafenoquine, and atovaquone-proguanil against Plasmodium cynomolgi in a rhesus monkey model.
    DiTusa C; Kozar MP; Pybus B; Sousa J; Berman J; Gettayacamin M; Im-erbsin R; Tungtaeng A; Ohrt C
    J Parasitol; 2014 Oct; 100(5):671-3. PubMed ID: 24780070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radical curative activity of a new 8-aminoquinoline derivative (CDRI 80/53) against Plasmodium cynomolgi B in monkeys.
    Dutta GP; Puri SK; Bhaduri AP; Seth M
    Am J Trop Med Hyg; 1989 Dec; 41(6):635-7. PubMed ID: 2641640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review: Improving the therapeutic index of 8-aminoquinolines by the use of drug combinations: review of the literature and proposal for future investigations.
    Myint HY; Berman J; Walker L; Pybus B; Melendez V; Baird JK; Ohrt C
    Am J Trop Med Hyg; 2011 Dec; 85(6):1010-4. PubMed ID: 22144436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemotherapy of rodent malaria XXXVI. Part IV. The activity of a new 8-aminoquinoline, WR 225,448 against exo-erythrocytic schizonts of Plasmodium yoelii yoelii.
    Peters W; Ellis D; Boulard Y; Landau I
    Ann Trop Med Parasitol; 1984 Oct; 78(5):467-78. PubMed ID: 6524991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfur-interrupted 8-amino side chain analogues of 4-methyl-5-[m-(trifluoromethyl)phenoxy]primaquine as potential antimalarial agents.
    Carroll FI; Berrang B; Linn CP
    J Med Chem; 1985 Dec; 28(12):1959-62. PubMed ID: 4068013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-aminoquinoline analogues and its platinum (II) complexes as antimalarial agents.
    de Souza NB; Carmo AM; Lagatta DC; Alves MJ; Fontes AP; Coimbra ES; da Silva AD; Abramo C
    Biomed Pharmacother; 2011 Jul; 65(4):313-6. PubMed ID: 21704476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimalarial activity of the 8-aminoquinolines.
    Nodiff EA; Chatterjee S; Musallam HA
    Prog Med Chem; 1991; 28():1-40. PubMed ID: 1843545
    [No Abstract]   [Full Text] [Related]  

  • 11. Tafenoquine: First Global Approval.
    Frampton JE
    Drugs; 2018 Sep; 78(14):1517-1523. PubMed ID: 30229442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From hybrid compounds to targeted drug delivery in antimalarial therapy.
    Oliveira R; Miranda D; Magalhães J; Capela R; Perry MJ; O'Neill PM; Moreira R; Lopes F
    Bioorg Med Chem; 2015 Aug; 23(16):5120-30. PubMed ID: 25913864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimalarials. 11. Synthesis of 3- and 5-aminoquinolines as potential antimalarials.
    Khan MS; LaMontagne MP
    J Med Chem; 1979 Aug; 22(8):1005-8. PubMed ID: 114654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chemotherapy of rodent malaria. LXI. Drug combinations to impede the selection of drug resistance, part 4: the potential role of 8-aminoquinolines.
    Peters W; Stewart LB; Robinson BL
    Ann Trop Med Parasitol; 2003 Apr; 97(3):221-36. PubMed ID: 12803854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimalarial benzoheterocyclic 4-aminoquinolines: Structure-activity relationship, in vivo evaluation, mechanistic and bioactivation studies.
    Ongarora DS; Strydom N; Wicht K; Njoroge M; Wiesner L; Egan TJ; Wittlin S; Jurva U; Masimirembwa CM; Chibale K
    Bioorg Med Chem; 2015 Sep; 23(17):5419-32. PubMed ID: 26264839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tafenoquine and primaquine do not exhibit clinical neurologic signs associated with central nervous system lesions in the same manner as earlier 8-aminoquinolines.
    Berman J; Brown T; Dow G; Toovey S
    Malar J; 2018 Nov; 17(1):407. PubMed ID: 30400893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evolution of tafenoquine--antimalarial for a new millennium?
    Peters W
    J R Soc Med; 1999 Jul; 92(7):345-52. PubMed ID: 10615272
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationships between chemical structures of 8-aminoquinolines and their capacities for radical cure of infections with Plasmodium cynomolgi in rhesus monkeys.
    Schmidt LH
    Antimicrob Agents Chemother; 1983 Nov; 24(5):615-52. PubMed ID: 6660845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appraisals of compounds of diverse chemical classes for capacities to cure infections with sporozoites of Plasmodium cynomolgi.
    Schmidt LH
    Am J Trop Med Hyg; 1983 Mar; 32(2):231-57. PubMed ID: 6837838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthesis of primaquine analogues and their antimalarial activity in mice].
    Jiang Q; Zhong J; Shi Y; Li G
    Yao Xue Xue Bao; 1998; 33(3):194-200. PubMed ID: 11938965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.